Читать книгу Pathy's Principles and Practice of Geriatric Medicine - Группа авторов - Страница 492
Sequelae of faecal incontinence
ОглавлениеFaecal incontinence is a marker for poor overall health and frailty and is associated with increased mortality in older adults, as well as institutionalization.8,45 Those with faecal incontinence have higher rates of urinary tract infection46 and significantly increased risk of pressure ulcers, particularly full‐thickness ulcers.47 Faecal incontinence is also associated with a significant reduction in quality of life. There are effects on the quality of life of both the sufferer and their family, as well as social isolation, impaired self‐esteem, and reduced sexual well‐being.5 Faeces are extremely damaging to skin, causing both direct damage and secondary infection with faecal organisms, and when mixed with urine, faecal urease causes urinary urea to be converted to ammonia, leading to greater skin damage.48
Table 19.1 Medications associated with faecal incontinence.
Medications implicated in diarrhoea or loose stool |
---|
Metformin |
Magnesium‐containing antacids |
Proton pump inhibitors |
Aminosalicylates |
Digoxin |
Methyldopa |
Antibiotics |
Acarbose |
Colchicine |
Non‐steroidal anti‐inflammatory drugs |
Sorbitol (found in sugar‐free preparations and confectionary) |
Laxatives |
Medications inducing constipation |
Opioids |
Drugs with anticholinergic effects |
Tricyclic antidepressants |
OAB medications |
Calcium channel blockers |
Loperamide |
Iron preparations |
Drugs increasing GI motility |
Metoclopramide |
Macrolide antibiotics |
Domperidone |
Drugs that alter anal sphincter tone |
Nitrates Beta blockers PDE‐5 inhibitors |
Faecal incontinence is associated with significant personal and healthcare resource use, although accurate data are sparse.6 Costs include both direct costs, such as containment products, care staff time, and laundry of clothes and bedsheets, and indirect costs, including work absenteeism of both the sufferer and their care partners, as well as dealing with complications of faecal incontinence such as UTIs. The total cost of faecal incontinence in the US is estimated to exceed $16 billion annually, and this is likely an underestimate.